Leibman Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Leibman Financial Services's BMY Position: Q2 2026 in Review
Leibman Financial Services increased its Bristol-Myers Squibb (BMY) stake by 3.1% in Q2 2026, buying an estimated $121K and bringing the position to 69,007 shares worth $3.98M. The position accounts for 2.64% of the portfolio, ranked #12.
Leibman Financial Services first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.06M in Q1 2026. 962 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Leibman Financial Services held 69,007 shares of Bristol-Myers Squibb worth $3.98M as of Q2 2026.
- Leibman Financial Services bought 2,100 Bristol-Myers Squibb shares in Q2 2026, an estimated $121K.
- Bristol-Myers Squibb made up 2.64% of Leibman Financial Services's portfolio in Q2 2026, its #12 holding.
- Leibman Financial Services first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Leibman Financial Services's Bristol-Myers Squibb position peaked at $4.06M in Q1 2026.
- 962 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Leibman Financial Services's 13F filing for Q2 2026, filed 14 Jul 2026.